A research by Sivina et al. showed that CXCL13 plasma concentrations were shown to be higher in CLL patients with active advanced stage illness, larger lymph nodes, and higher CLL cell birth rates [23]. This evidence concerns the gene CXCL13 and B-cell chronic lymphocytic leukemia.